Table 1.

R2* and fat fraction (PDFF) in the liver and spine before and after SPIO administration. The liver data for subject 13 was not included due to breathing motion artifact.

Subject	Liver R2* (s−1)		Liver PDFF (%)		Spine R2* (s−1)		Spine PDFF (%)
	Pre	Post	Pre	Post	Pre	Post	Pre	Post
1	85.5	190.6	5.4	7.7	156.6	195.3	39.4	45.0
2	16.2	178.8	8.5	7.5	128.1	198.1	46.5	46.9
3	55.0	178.6	22.0	20.2	144.9	146.9	31.1	27.9
4	57.9	127.3	1.0	0.8	199.4	275.1	57.1	57.6
5	49.1	127.1	33.3	33.5	123.8	162.0	24.4	27.3
6	47.3	158.4	3.2	4.8	160.3	188.1	34.7	36.4
7	39.0	186.7	6.1	4.8	159.4	194.1	38.0	40.3
8	49.2	169.6	11.9	12.0	166.3	164.9	29.9	29.1
9	48.5	134.5	14.8	14.3	198.6	221.7	38.2	37.9
10	37.0	80.1	9.5	7.1	116.5	141.8	40.5	37.7
11	35.4	155.2	1.9	2.8	133.9	149.3	52.1	51.8
12	38.6	113.9	3.8	5.1	286.8	303.1	38.6	39.8
13	-	-	-	-	148.6	138.4	53.0	52.5
14	92.4	212.0	10.9	8.2	291.5	254.3	45.2	43.9
Mean Difference	104.7		−0.27		22.7		0.37
p-value	8.8 × 10−8		5.5 × 10−1		1.3 × 10−2		5.6 × 10−1